Literature DB >> 10951564

Nuclear import and subnuclear localization of the proto-oncoprotein ETO (MTG8).

Y Odaka1, A Mally, L T Elliott, S Meyers.   

Abstract

ETO (MTG8) was first described due to its involvement in the (8;21) translocation frequently observed in acute myeloid leukemias. In the t(8;21) the AML1 gene on chromosome 21 is fused to ETO on chromosome 8. The resultant hybrid protein is comprised of the DNA binding domain of AML-1 and the majority of ETO. This study examines the subnuclear distributions of ETO, AML-1B and AML-1/ETO proteins fused to green fluorescence protein in living cells using fluorescence microscopy. Further, we identified a 40 amino acid portion of ETO (amino acids 241-280) that was sufficient to cause nuclear import of green fluorescent protein. Mutational analysis demonstrated that lysine 265 and/or arginine 266 were required for nuclear import of ETO, but that the surrounding basic residues were not critical. ETO interacted with the nuclear import proteins importin-alpha and beta in vitro, and mutations in ETO that abolish nuclear localization also abolished the in vitro interaction with importin-alpha and beta. These data suggest that ETO enters the nucleus via an importin-mediated pathway. Additionally, ETO and AML-1/ETO co-localized to punctate nuclear bodies distinct from those containing promyelocytic leukemia protein. Nuclear body formation was dependent upon a region of ETO N-terminal to the nuclear localization signal. Thus, ETO and AML-1/ETO reside in potentially novel subnuclear compartments.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10951564     DOI: 10.1038/sj.onc.1203689

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

Review 1.  Role of RUNX1 in hematological malignancies.

Authors:  Raman Sood; Yasuhiko Kamikubo; Paul Liu
Journal:  Blood       Date:  2017-02-08       Impact factor: 22.113

2.  Multiple subnuclear targeting signals of the leukemia-related AML1/ETO and ETO repressor proteins.

Authors:  Karina Barseguian; Bart Lutterbach; Scott W Hiebert; Jeffrey Nickerson; Jane B Lian; Janet L Stein; Andre J van Wijnen; Gary S Stein
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-11       Impact factor: 11.205

3.  ANTI-MTG16 ANTIBODIES REVEAL MTG16 SUBCELLULAR DISTRIBUTION AND NUCLEOCYTOPLASMIC TRANSPORT IN ERYTHROLEUKEMIA CELLS.

Authors:  Hong Nguyen; Jolene Mariotti; Diana Bareyan; Robert Carnahan; Tracy Cooper; Christopher Williams; Michael Engel
Journal:  Antib Technol J       Date:  2015-02-19

Review 4.  Emerging Roles of MTG16 in Cell-Fate Control of Hematopoietic Stem Cells and Cancer.

Authors:  Nickolas Steinauer; Chun Guo; Jinsong Zhang
Journal:  Stem Cells Int       Date:  2017-11-22       Impact factor: 5.443

Review 5.  RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia.

Authors:  Emiel van der Kouwe; Philipp Bernhard Staber
Journal:  Int J Mol Sci       Date:  2019-01-16       Impact factor: 5.923

Review 6.  Targeting nuclear import and export in hematological malignancies.

Authors:  Boaz Nachmias; Aaron D Schimmer
Journal:  Leukemia       Date:  2020-07-05       Impact factor: 11.528

Review 7.  t(8;21) Acute Myeloid Leukemia as a Paradigm for the Understanding of Leukemogenesis at the Level of Gene Regulation and Chromatin Programming.

Authors:  Sophie Kellaway; Paulynn S Chin; Farnaz Barneh; Constanze Bonifer; Olaf Heidenreich
Journal:  Cells       Date:  2020-12-13       Impact factor: 6.600

8.  ETO/MTG8 is an inhibitor of C/EBPbeta activity and a regulator of early adipogenesis.

Authors:  Justin J Rochford; Robert K Semple; Matthias Laudes; Keith B Boyle; Constantinos Christodoulides; Claire Mulligan; Christopher J Lelliott; Sven Schinner; Dirk Hadaschik; Meera Mahadevan; Jaswinder K Sethi; Antonio Vidal-Puig; Stephen O'Rahilly
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

9.  RUNX1T1, a potential prognostic marker in breast cancer, is co-ordinately expressed with ERα, and regulated by estrogen receptor signalling in breast cancer cells.

Authors:  Snigdha Saikia; Uttariya Pal; Deep Jyoti Kalita; Avdhesh Kumar Rai; Anupam Sarma; Amal Chandra Kataki; Anil Mukund Limaye
Journal:  Mol Biol Rep       Date:  2021-07-15       Impact factor: 2.316

10.  The human SIN3B corepressor forms a nucleolar complex with leukemia-associated ETO homologues.

Authors:  Rakesh Singh Dhanda; Sofia Rondin Lindberg; Inge Olsson
Journal:  BMC Mol Biol       Date:  2008-01-19       Impact factor: 2.946

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.